Detalhe da pesquisa
1.
A novel subgenotype I3 of hepatitis B virus in Guangxi, China: a 15-year follow-up study.
Virus Genes;
59(3): 359-369, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36841897
2.
Infection with Hepatitis B Virus May Increase the Serum Concentrations of Osteopontin.
Intervirology;
64(3): 126-134, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33735879
3.
Novel subgenotype D11 of hepatitis B virus in NaPo County, Guangxi, bordering Vietnam.
J Gen Virol;
100(5): 828-837, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30990399
4.
Asymptomatic hepatitis B carriers who were vaccinated at birth.
J Med Virol;
91(8): 1489-1498, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30883792
5.
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Intervirology;
61(3): 123-132, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30368502
6.
Hepatitis B Virus Core Promoter Double Mutations (A1762T, G1764A) Are Associated with Lower Levels of Serum Dihydrolipoyl Dehydrogenase.
Intervirology;
59(1): 1-7, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27303803
7.
Malaria imported from Ghana by returning gold miners, China, 2013.
Emerg Infect Dis;
21(5): 864-7, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25897805
8.
The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.
J Med Virol;
87(8): 1351-60, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25879734
9.
Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.
Intervirology;
57(5): 270-6, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24994115
10.
Hepatitis B virus candidate subgenotype I1 varies in distribution throughout Guangxi, China and may have originated in Long An county, Guangxi.
J Med Virol;
85(5): 799-807, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23508905
11.
Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Liver Int;
33(6): 936-43, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23517325
12.
Low host immune pressure may be associated with the development of hepatocellular carcinoma: a longitudinal analysis of complete genomes of the HBV 1762T, 1764A mutant.
Front Oncol;
13: 1214423, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37681020
13.
Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization.
J Med Virol;
84(6): 878-84, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22499009
14.
Analysis of entire hepatitis B virus genomes reveals reversion of mutations to wild type in natural infection, a 15 year follow-up study.
Infect Genet Evol;
97: 105184, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34902556
15.
A complex hepatitis B virus (X/C) recombinant is common in Long An county, Guangxi and may have originated in southern China.
J Gen Virol;
92(Pt 2): 402-11, 2011 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20965984
16.
Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China.
Hum Vaccin Immunother;
17(3): 845-851, 2021 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961084
17.
Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination.
Cancer Epidemiol;
67: 101775, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32623359
18.
[A prospective study of the relationship between serum hepatitis B virus DNA and the risk of primary liver cancer].
Zhonghua Gan Zang Bing Za Zhi;
17(12): 930-4, 2009 Dec.
Artigo
em Zh
| MEDLINE
| ID: mdl-20038336
19.
Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis.
Open Forum Infect Dis;
6(3): ofz040, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30863789
20.
HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.
Am J Gastroenterol;
103(9): 2254-62, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18844615